13F HOLDINGS REPORT
5AM Venture Management, LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001104659-23-091386
Total Value
$401.4M
Positions
24
Other Managers
0
Confidential Omitted
No
Holdings (24)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ENLIVEN THERAPEUTICS INC | ELVN | 5,798,475 | $118.3M | 29.48% |
| 2 | ENTRADA THERAPEUTICS INC | TRDA | 4,408,379 | $66.7M | 16.63% |
| 3 | DISC MEDICINE INC | IRON | 488,442 | $21.7M | 5.40% |
| 4 | RALLYBIO CORP | RLYB | 3,630,724 | $20.5M | 5.12% |
| 5 | VOR BIOPHARMA INC | VOR | 6,361,723 | $19.7M | 4.90% |
| 6 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 357,486 | $18.2M | 4.54% |
| 7 | CRINETICS PHARMACEUTICALS IN | CRNX | 862,286 | $15.5M | 3.87% |
| 8 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 490,000 | $13.8M | 3.44% |
| 9 | SCPHARMACEUTICALS INC | 810648105 | 1,200,647 | $12.2M | 3.05% |
| 10 | CELLDEX THERAPEUTICS INC NEW | CLDX | 310,270 | $10.5M | 2.62% |
| 11 | VIKING THERAPEUTICS INC | VKTX | 585,000 | $9.5M | 2.36% |
| 12 | COGENT BIOSCIENCES INC | COGT | 790,440 | $9.4M | 2.33% |
| 13 | PHARVARIS N V | PHVS | 587,600 | $8.9M | 2.22% |
| 14 | ARVINAS INC | ARVN | 320,000 | $7.9M | 1.98% |
| 15 | AVIDITY BIOSCIENCES INC | 05370A108 | 665,555 | $7.4M | 1.84% |
| 16 | ANAPTYSBIO INC | ANABV | 357,733 | $7.3M | 1.81% |
| 17 | MIRATI THERAPEUTICS INC | 60468T105 | 192,500 | $7.0M | 1.73% |
| 18 | VIRIDIAN THERAPEUTICS INC | VRDN | 280,000 | $6.7M | 1.66% |
| 19 | SPRUCE BIOSCIENCES INC | SPRB | 2,364,000 | $5.1M | 1.27% |
| 20 | MERSANA THERAPEUTICS INC | 59045L106 | 1,305,000 | $4.3M | 1.07% |
| 21 | HOMOLOGY MEDICINES INC | 438083107 | 4,535,919 | $4.0M | 1.00% |
| 22 | IMPEL PHARMACEUTICALS INC | 45258K109 | 2,884,791 | $3.7M | 0.91% |
| 23 | GH RESEARCH PLC | GHRS | 152,022 | $1.8M | 0.45% |
| 24 | CIDARA THERAPEUTICS INC | 171757107 | 1,134,511 | $1.3M | 0.32% |